These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 1740372

  • 1. Hyperthermia reduces the occurrence of proliferative vitreoretinopathy in a rabbit model.
    Yoshimura N, Kuriyama S, Ohuchi T, Takemura M, Honda Y, Hiraoka M.
    Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):404-9. PubMed ID: 1740372
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Liposome-encapsulated 5-fluorouracil in the treatment of proliferative vitreoretinopathy.
    Joondeph BC, Peyman GA, Khoobehi B, Yue BY.
    Ophthalmic Surg; 1988 Apr; 19(4):252-6. PubMed ID: 3362494
    [Abstract] [Full Text] [Related]

  • 8. [Evaluation of experimental proliferative vitreoretinopathy in rabbits].
    Kuriyama S, Ohuchi T, Okada M, Yamakawa R, Yoshimura N, Honda Y.
    Nippon Ganka Gakkai Zasshi; 1990 Sep; 94(9):792-8. PubMed ID: 2248164
    [Abstract] [Full Text] [Related]

  • 9. Liposome suppression of proliferative vitreoretinopathy. Rabbit model using antimetabolite encapsulated liposomes.
    Assil KK, Hartzer M, Weinreb RN, Nehorayan M, Ward T, Blumenkranz M.
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2891-7. PubMed ID: 1917392
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of drug treatments for proliferative vitreoretinopathy using vitreous microtensiometry.
    Moorhead LC, Sepahban S, Armeniades CD.
    Ann Ophthalmol; 1991 Sep; 23(9):349-55. PubMed ID: 1741609
    [Abstract] [Full Text] [Related]

  • 13. Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy.
    Araiz JJ, Refojo MF, Arroyo MH, Leong FL, Albert DM, Tolentino FI.
    Invest Ophthalmol Vis Sci; 1993 Mar; 34(3):522-30. PubMed ID: 8449673
    [Abstract] [Full Text] [Related]

  • 14. Preretinal membrane formation in rabbit eyes after intravitreal transplantation of cultured astrocytes.
    Mishima N, Yamashita H, Ishii Y, Hori S.
    Jpn J Ophthalmol; 1989 Mar; 33(4):501-18. PubMed ID: 2696800
    [Abstract] [Full Text] [Related]

  • 15. Heat effects on the retina.
    Piyathaisere DV, Margalit E, Chen SJ, Shyu JS, D'Anna SA, Weiland JD, Grebe RR, Grebe L, Fujii G, Kim SY, Greenberg RJ, De Juan E, Humayun MS.
    Ophthalmic Surg Lasers Imaging; 2003 Mar; 34(2):114-20. PubMed ID: 12665226
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of radiation therapy for experimental proliferative vitreoretinopathy in rabbits.
    Kuriyama S, Ohuchi T, Yoshimura N, Honda Y, Hiraoka M, Abe M.
    Graefes Arch Clin Exp Ophthalmol; 1990 Mar; 228(6):552-5. PubMed ID: 2265771
    [Abstract] [Full Text] [Related]

  • 17. A new model of proliferative vitreoretinopathy.
    Frenzel EM, Neely KA, Walsh AW, Cameron JD, Gregerson DS.
    Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2157-64. PubMed ID: 9761295
    [Abstract] [Full Text] [Related]

  • 18. [Experimental studies of proliferative vitreoretinopathy].
    Kain HL.
    Fortschr Ophthalmol; 1991 Oct; 88(6):671-6. PubMed ID: 1794788
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of adriamycin on experimental proliferative vitreoretinopathy in the rabbit.
    Sunalp MA, Wiedemann P, Sorgente N, Ryan SJ.
    Exp Eye Res; 1985 Jul; 41(1):105-15. PubMed ID: 4029281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.